A study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors.
Roy S. Herbst
Research Funding - Genentech
Michael S. Gordon
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Gregg Daniel Fine
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Jeffrey Alan Sosman
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Jean-Charles Soria
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Omid Hamid
Honoraria - Genentech
Research Funding - Genentech
John D. Powderly
Employment or Leadership Position - BioCytics
Consultant or Advisory Role - Genentech/Roche
Stock Ownership - BioCytics
Honoraria - Bristol-Myers Squibb; Genentech
Research Funding - Amgen; Bristol-Myers Squibb; Celldex; Genentech; ImClone Systems; Lilly; Millennium
Howard A. Burris
No relevant relationships to disclose
Ahmad Mokatrin
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Maya Leabman
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Maria Anderson
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Genentech/Roche
Daniel S. Chen
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
F. Stephen Hodi
Consultant or Advisory Role - Genentech
Research Funding - Genentech